BCRX
Price
$11.04
Change
+$0.06 (+0.55%)
Updated
Jun 6 closing price
Capitalization
2.3B
54 days until earnings call
COGT
Price
$6.80
Change
+$0.81 (+13.52%)
Updated
Jun 6 closing price
Capitalization
680.86M
66 days until earnings call
Interact to see
Advertisement

BCRX vs COGT

Header iconBCRX vs COGT Comparison
Open Charts BCRX vs COGTBanner chart's image
BioCryst Pharmaceuticals
Price$11.04
Change+$0.06 (+0.55%)
Volume$4.09M
Capitalization2.3B
Cogent Biosciences
Price$6.80
Change+$0.81 (+13.52%)
Volume$2.72M
Capitalization680.86M
BCRX vs COGT Comparison Chart
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. COGT commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Hold and COGT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BCRX: $11.04 vs. COGT: $6.80)
Brand notoriety: BCRX: Notable vs. COGT: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 81% vs. COGT: 186%
Market capitalization -- BCRX: $2.3B vs. COGT: $680.86M
BCRX [@Biotechnology] is valued at $2.3B. COGT’s [@Biotechnology] market capitalization is $680.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, BCRX is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 3 TA indicator(s) are bullish while COGT’s TA Score has 5 bullish TA indicator(s).

  • BCRX’s TA Score: 3 bullish, 5 bearish.
  • COGT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, COGT is a better buy in the short-term than BCRX.

Price Growth

BCRX (@Biotechnology) experienced а +2.70% price change this week, while COGT (@Biotechnology) price change was +25.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

BCRX is expected to report earnings on Jul 31, 2025.

COGT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($2.3B) has a higher market cap than COGT($681M). BCRX YTD gains are higher at: 46.809 vs. COGT (-12.821). BCRX has higher annual earnings (EBITDA): 47.6M vs. COGT (-284.04M). BCRX has more cash in the bank: 295M vs. COGT (246M). COGT has less debt than BCRX: COGT (17.1M) vs BCRX (795M). BCRX has higher revenues than COGT: BCRX (503M) vs COGT (0).
BCRXCOGTBCRX / COGT
Capitalization2.3B681M337%
EBITDA47.6M-284.04M-17%
Gain YTD46.809-12.821-365%
P/E RatioN/AN/A-
Revenue503M0-
Total Cash295M246M120%
Total Debt795M17.1M4,649%
FUNDAMENTALS RATINGS
BCRX vs COGT: Fundamental Ratings
BCRX
COGT
OUTLOOK RATING
1..100
5923
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
6968
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
3858
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (32) in the Biotechnology industry is somewhat better than the same rating for COGT (81) in the Miscellaneous industry. This means that BCRX’s stock grew somewhat faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (68) in the Miscellaneous industry is in the same range as BCRX (69) in the Biotechnology industry. This means that COGT’s stock grew similarly to BCRX’s over the last 12 months.

COGT's SMR Rating (96) in the Miscellaneous industry is in the same range as BCRX (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to BCRX’s over the last 12 months.

BCRX's Price Growth Rating (38) in the Biotechnology industry is in the same range as COGT (58) in the Miscellaneous industry. This means that BCRX’s stock grew similarly to COGT’s over the last 12 months.

BCRX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that BCRX’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRXCOGT
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGVNX27.29N/A
N/A
TCW Relative Value Mid Cap N
GTFPX31.55N/A
N/A
Goldman Sachs International Eq ESG P
VBIAX48.52N/A
N/A
Vanguard Balanced Index Adm
EQICX12.61N/A
N/A
Allspring Emerging Markets Eq Advtg C
FIKCX60.02N/A
N/A
Fidelity Advisor Health Care Z

BCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
+0.55%
VCYT - BCRX
46%
Loosely correlated
+1.78%
CRNX - BCRX
40%
Loosely correlated
+2.13%
INSM - BCRX
39%
Loosely correlated
+1.21%
COGT - BCRX
39%
Loosely correlated
+13.52%
VKTX - BCRX
39%
Loosely correlated
+2.92%
More